# Mail Order Mifepristone Study

> **NCT03913104** · PHASE4 · COMPLETED · sponsor: **Daniel Grossman, MD** · enrollment: 536 (actual)

## Conditions studied

- Abortion Early
- Pregnancy Related

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT03913104
- **Lead sponsor:** Daniel Grossman, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-05
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 536 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03913104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03913104, "Mail Order Mifepristone Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03913104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*